Mark McClellan
Mark McClellan
Mark Barr McClellanis the Director of the Robert J Margolis Center for Health Policy and the Margolis Professor of Business, Medicine and Health Policy at Duke University. Formerly, he was a senior fellow and director of the Health Care Innovation and Value Initiative at the Engelberg Center for Health Care Reform at The Brookings Institution, in Washington, D.C. McClellan served as Commissioner of the United States Food and Drug Administration under President George W. Bush from 2002 through 2004,...
deep people rush time
People do have time to take a deep breath. They don't need to rush into a decision.
drop employers proven
There had been predictions that employers would drop drug coverage, but that's proven wrong.
acute adult assistant care clearly coordinate health programs seems services
Adult day care programs (and) assistant programs like that clearly have a big impact. It seems like it would make sense to coordinate those services with acute health care.
advantage help interested resources savings saying senior taking worth
They are overwhelmingly saying it is worth the effort, and they will get savings and security, and in many cases, more savings than they expected. And we have the resources to help any other senior who is interested in taking advantage of the same program.
continue december faster late saw seen steady
We've seen enrollment continue at a steady pace, faster than what we saw before the late December surge.
benefit concerns coverage medicare
CMS has significant concerns about the GAO's finding. These individuals will get effective, comprehensive prescription-drug coverage when the new Medicare prescription-drug benefit begins.
choices outcomes information
Food choices affect health outcomes, and consumers need to have the latest, most up-to-date scientific information in making their food choices.
real light medicine
Pharmacogenomics holds great promise to shed scientific light on the often risky and costly process of drug development, and to provide greater confidence about the risks and benefits of drugs in specific populations. Pharmacogenomics is a new field, but we intend to do all we can to use it to promote the development of medicines. By providing practical guidance on how to turn the explosion of pharmacogenomic information into real evidence on new drugs, we are taking an important step toward that goal.
care colorado committing health pleased
I am pleased to see Colorado committing to the health care of children.
benefit leaves needs sure work
The benefit needs to work for everyone. We're working ... to make sure that no one leaves without the prescriptions that they need.
evidence immediate leave plan
They'll be able to leave the pharmacy with their prescription in hand, even if there is not immediate evidence of what plan they're in.
diseases money paying
It just doesn't make sense for us to be paying that much money on complications of diseases we can prevent.
help medicare people start thinking time
It's time for people with Medicare and those who care about them to start thinking about making Medicare decisions. And we will help them.
avoid both challenge costs drive health help people save steps wherever
The challenge in policymaking is to take all the steps we can to help avoid unnecessary costs, to help people save money, to drive costs down wherever possible. That's the way to have both affordability and better and better health care.